• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Digirad signs distribution deal with NIR

Article

Digital gamma camera developer Digirad of San Diego announced this month that it has signed a distribution and service agreement with National Imaging Resources for its Digirad 2020 TC Imager. Birmingham, AL-based NIR will gain U.S. distribution rights

Digital gamma camera developer Digirad of San Diego announced this month that it has signed a distribution and service agreement with National Imaging Resources for its Digirad 2020 TC Imager. Birmingham, AL-based NIR will gain U.S. distribution rights to the system, which uses solid-state detectors made from cadmium zinc telluride.

The agreement gives Digirad access to a strong sales structure it has not had before: NIR boasts 190 sales representatives, a 400-member service organization, and a regional network consisting of more than 50 locations. But NIR also expects to benefit from the deal, gaining access to the nuclear medicine market. NIR reports annual sales of more than $500 million.

The deal further strengthens Digirad's market position, especially in light of patents the company received last month that cover a method of manufacturing solid-state digital detector modules (SCAN 10/28/98). Digirad 2020 TC Imager was cleared by the Food and Drug Administration in June 1997 (SCAN 6/11/97).

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.